These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26692289)

  • 1. Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword.
    Zhou D; Tan RJ; Fu H; Liu Y
    Lab Invest; 2016 Feb; 96(2):156-67. PubMed ID: 26692289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wnt/β-catenin signaling in kidney repair and fibrosis after injury].
    Ren Q; Chen JC; Liu Y
    Sheng Li Xue Bao; 2022 Feb; 74(1):15-27. PubMed ID: 35199122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor protects against acute kidney injury via the Wnt/β-catenin signaling pathway.
    Xu ZH; Wang C; He YX; Mao XY; Zhang MZ; Hou YP; Li B
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F611-F624. PubMed ID: 35403451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression.
    Xiao L; Zhou D; Tan RJ; Fu H; Zhou L; Hou FF; Liu Y
    J Am Soc Nephrol; 2016 Jun; 27(6):1727-40. PubMed ID: 26453613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.
    Zhang L; Adu IK; Zhang H; Wang J
    Int Urol Nephrol; 2023 Oct; 55(10):2527-2538. PubMed ID: 36964322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease.
    Huffstater T; Merryman WD; Gewin LS
    Semin Nephrol; 2020 Mar; 40(2):126-137. PubMed ID: 32303276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT-β-catenin signalling - a versatile player in kidney injury and repair.
    Schunk SJ; Floege J; Fliser D; Speer T
    Nat Rev Nephrol; 2021 Mar; 17(3):172-184. PubMed ID: 32989282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the role and mechanism of Wnt/β-catenin signalling in kidney fibrosis.
    Zuo Y; Liu Y
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():38-43. PubMed ID: 30298654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 accelerates renal fibrosis after acute kidney injury via DNMT1-dependent FOXO3a methylation and activation of Wnt/β-catenin pathway.
    Guo X; Zhu Y; Sun Y; Li X
    Int Immunopharmacol; 2022 Aug; 109():108746. PubMed ID: 35569307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3β and CK1α.
    Sun Y; Fan Y; Wang Z; Li M; Su D; Liu Y; Liang X
    Cell Mol Life Sci; 2022 Mar; 79(3):184. PubMed ID: 35279748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.
    Hu J; Qiao J; Yu Q; Liu B; Zhen J; Liu Y; Ma Q; Li Y; Wang Q; Wang C; Lv Z
    J Transl Med; 2021 Feb; 19(1):69. PubMed ID: 33588892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
    Senouthai S; Wang J; Fu D; You Y
    Inflammation; 2019 Aug; 42(4):1287-1300. PubMed ID: 30919150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling and kidney fibrosis.
    Tan RJ; Zhou D; Zhou L; Liu Y
    Kidney Int Suppl (2011); 2014 Nov; 4(1):84-90. PubMed ID: 26312156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Wnt/Beta-Catenin Signaling Network as Emerging Signaling Cascade for Therapeutic Intervention in Chronic Renal Disease.
    Soni H
    Curr Drug Targets; 2021; 22(16):1825-1831. PubMed ID: 33593258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/β-Catenin Signaling.
    Dong X; Cao R; Li Q; Yin L
    Nephron; 2022; 146(2):209-219. PubMed ID: 34818249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt Signaling in Kidney Development and Disease.
    Wang Y; Zhou CJ; Liu Y
    Prog Mol Biol Transl Sci; 2018 Jan; 153():181-207. PubMed ID: 29389516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.
    Ogbadu J; Singh G; Aggarwal D
    Eur J Pharmacol; 2019 Dec; 865():172711. PubMed ID: 31589870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
    Jiao X; Cai J; Yu X; Ding X
    Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease.
    Yeh TH; Tu KC; Wang HY; Chen JY
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition.
    Kuang Q; Wu S; Xue N; Wang X; Ding X; Fang Y
    Front Pharmacol; 2021; 12():667282. PubMed ID: 34122087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.